Detalhe da pesquisa
1.
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Thromb Res
; 232: 133-137, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976733
2.
New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2.
World J Clin Oncol
; 13(4): 276-286, 2022 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582653
3.
Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.
Clin Transl Oncol
; 24(10): 2010-2020, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668339
4.
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments.
Eur J Cancer
; 166: 229-239, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316750
5.
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature.
Transl Lung Cancer Res
; 10(7): 3303-3311, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430366
6.
Targeting KRAS in Non-Small Cell Lung Cancer.
Front Oncol
; 11: 792635, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083149
7.
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report.
Case Rep Oncol Med
; 2021: 5526809, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34306781